Patents by Inventor Melisande Richard

Melisande Richard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7094396
    Abstract: The methods of this invention relate to immunizing animals with conjugates of cytokines and a carrier to induce a prolonged high titre antibody response specific for the cytokine. This invention also relates to the treatment of pathological conditions, e.g., eosinophilia and allograft rejection, associated with the production of cytokines, in particular interleukins, e.g., IL-4, IL-5, IL-9, and IL-13, by immunization with the cytokine conjugates or by administration of antibodies specific for the cytokine. This invention also relates to compositions comprising the cytokine conjugates and the conjugates per se.
    Type: Grant
    Filed: August 8, 2003
    Date of Patent: August 22, 2006
    Assignee: Ludwig Institiute for Cancer Research
    Inventors: Jacques Van Snick, Jean Christophe Renauld, Mélisande Richard
  • Publication number: 20040028650
    Abstract: The methods of this invention relate to immunizing animals with conjugates of cytokines and a carrier to induce a prolonged high titre antibody response specific for the cytokine. This invention also relates to the treatment of pathological conditions, e.g., eosinophilia and allograft rejection, associated with the production of cytokines, in particular interleukins, e.g., IL-4, IL-5, IL-9, and IL-13, by immunization with the cytokine conjugates or by administration of antibodies specific for the cytokine. This invention also relates to compositions comprising the cytokine conjugates and the conjugates per se.
    Type: Application
    Filed: August 8, 2003
    Publication date: February 12, 2004
    Inventors: Jacques Van Snick, Jean Christophe Renauld, Melisande Richard
  • Patent number: 6645486
    Abstract: The methods of this invention relate to immunizing animals with conjugates of cytokines and a carrier to induce a prolonged high titre antibody response specific for the cytokine. This invention also relates to the treatment of pathological conditions, e.g., eosinophilia and allograft rejection, associated with the production of cytokines, in particular interleukins, e.g., IL-4, IL-5, IL-9, and IL-13, by immunization with the cytokine conjugates or by administration of antibodies specific for the cytokine. This invention also relates to compositions comprising the cytokine conjugates and the conjugates per se.
    Type: Grant
    Filed: January 25, 2000
    Date of Patent: November 11, 2003
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Jacques Van Snick, Jean Christophe Renauld, Mélisande Richard